InsidersTradesSigma
Follow the ACRUX LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Market capitalisation: €6.8m. The latest transaction was disclosed on 2 June 2026 (Purchase). Among the most active insiders: Unknown. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
ACRUX LIMITED is a company listed on the XASX market, specializing in the development of pharmaceutical products. It focuses on innovative solutions to improve patient health.